Anti-SART1 Antibody

SART1 (Squamous Cell Carcinoma Antigen Recognized By T Cells 1) participates in mRNA splicing as part of the U4/U6.U5 tri-snRNP complex and has been investigated as a tumor-associated antigen recognized by HLA class I-restricted cytotoxic T lymphocytes. The Antibodies.com polyclonal reagent is raised in rabbit and affinity-purified to bind a nuclear epitope of human SART1, expressed across multiple tissue types.

Each vial contains 100 µl of unconjugated IgG suitable for Western blot detection of the SART1 protein in cell lysates, immunohistochemical localization in fixed tissue sections, and immunofluorescence staining of nuclear speckles in cultured cells. The antibody is validated for reactivity with human samples and is intended for research use only in immunology, cancer immunotherapy, and RNA splicing studies.

Storage at -20 °C in small aliquots helps preserve activity across multiple freeze-thaw cycles.